Literature DB >> 2647552

Risk factors for progression of background retinopathy in long-standing IDDM.

H U Janka1, J H Warram, L I Rand, A S Krolewski.   

Abstract

Risk factors for the development of severe forms of diabetic retinopathy were examined prospectively in a group of 153 patients with long-standing insulin-dependent diabetes mellitus. During a 4-yr follow-up study, 34 individuals progressed to preproliferative and proliferative retinopathy. The risk of progression to severe forms of diabetic retinopathy was determined by the degree of background diabetic retinopathy and several systemic factors. It increased steeply with hemoglobin A1c, declined proportionally with increasing age, and was dramatically different in patients with diastolic blood pressure below versus above 70 mmHg. Although the mechanisms of action of these systemic factors are unclear, the findings emphasize the multifactorial nature of the pathogenesis of severe forms of eye lesions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2647552     DOI: 10.2337/diab.38.4.460

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  17 in total

Review 1.  Hypertension and diabetic retinopathy--what's the story?

Authors:  J T Gillow; J M Gibson; P M Dodson
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

2.  Macular circulation in patients with diabetes mellitus with and without arterial hypertension.

Authors:  O Arend; M Rüffer; A Remky
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 3.  [Normoglycemia as a therapy goal in diabetes treatment--concept and realization].

Authors:  E G Siegel
Journal:  Klin Wochenschr       Date:  1990-03-16

4.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

5.  Prevalence and risk factors for diabetic retinopathy among Omani diabetics.

Authors:  O A el Haddad; M K Saad
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

6.  Aminoguanidine does not inhibit the initial phase of experimental diabetic retinopathy in rats.

Authors:  H P Hammes; S S Ali; M Uhlmann; A Weiss; K Federlin; K Geisen; M Brownlee
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.

Authors: 
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

8.  The association between skin collagen glucosepane and past progression of microvascular and neuropathic complications in type 1 diabetes.

Authors:  Vincent M Monnier; David R Sell; Christopher Strauch; Wanjie Sun; John M Lachin; Patricia A Cleary; Saul Genuth
Journal:  J Diabetes Complications       Date:  2012-11-12       Impact factor: 2.852

9.  Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.

Authors:  Q Z Liu; D J Pettitt; R L Hanson; M A Charles; R Klein; P H Bennett; W C Knowler
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

10.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.

Authors:  Jorge Esteves; Carolina Maurente da Rosa; Caroline Kaercher Kramer; Luiz Eduardo Osowski; Stéfano Milano; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.